Quote | Biocure Technology Inc. (CNQC:CURE:CC)
Last: | $0.05 |
---|---|
Change Percent: | 0.0% |
Open: | $0.05 |
Close: | $0.05 |
High: | $0.05 |
Low: | $0.05 |
Volume: | 7,800 |
Last Trade Date Time: | 04/25/2022 04:56:06 pm |
News | Biocure Technology Inc. (CNQC:CURE:CC)
Canadian Investment Regulatory Organization Trade Resumption - CURE.X Canada NewsWire VANCOUVER, BC , July 4, 2024 /CNW/ - Trading resumes in: Company: Biocure Technology Inc. CSE Symbol: CURE.X All Issues: Yes Resumption (ET): 9:30 AM 7/5/2024 ...
Atriva Therapeutics and Canadian Biocure Technologies, Inc. entered into an exclusive letter agreement for a reverse takeover transaction. Upon successful completion of the transaction, the resulting entity will continue the business of Atriva Therapeutics. Shareholders of Atriva ...
Message Board Posts | Biocure Technology Inc. (CNQC:CURE:CC)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Biocure Technology Inc. Company Name:
CURE:CC Stock Symbol:
CNQC Market:
Canadian Investment Regulatory Organization Trade Resumption - CURE.X Canada NewsWire VANCOUVER, BC , July 4, 2024 /CNW/ - Trading resumes in: Company: Biocure Technology Inc. CSE Symbol: CURE.X All Issues: Yes Resumption (ET): 9:30 AM 7/5/2024 ...
Atriva Therapeutics and Canadian Biocure Technologies, Inc. entered into an exclusive letter agreement for a reverse takeover transaction. Upon successful completion of the transaction, the resulting entity will continue the business of Atriva Therapeutics. Shareholders of Atriva ...
Vancouver, British Columbia--(Newsfile Corp. - September 18, 2023) - Biocure Technology Inc. (CSE: CURE) ("CURE" or the "Company") announces that it has entered into an exclusive letter agreement dated September 8, 2023 with Atriva Therapeutics GmbH. ("Atriva") whereby the Company will acquire al...